Astec Lifesciences
Share prices of Godrej Ind, Godrej Properties, Astec Lifesciences drop
Godrej Industries shares fell by 7 per cent to Rs 893 a share, while Godrej property's share fell by 4.4 percent to Rs 2,532 a share
 "Share prices of Godrej Ind, Godrej Properties, Astec Lifesciences drop")
Biz split impact: Godrej stocks rally up to 9%; Godrej Properties down 4%
Shares of Godrej Group companies rallied up to 9 per cent in Thursday's trading session after the Group announced a split in the 127-year old family business.
 "Biz split impact: Godrej stocks rally up to 9%; Godrej Properties down 4%")
Godrej family splits: How to trade listed top Godrej stocks on BSE, NSE?
Technical outlook on Godrej group listed stocks: Shares of Godrej family have delivered mind-boggling returns of up to 73 fold in the past years. Here's what to expect in the near term.
 "Godrej family splits: How to trade listed top Godrej stocks on BSE, NSE?")
Adi-Nadir Godrej family makes open offer to acquire Astec Lifesciences
To acquire 20.84% stake in Godrej Industries from Jamshyd Godrej family
 "Adi-Nadir Godrej family makes open offer to acquire Astec Lifesciences")
Strategies for Godrej stocks as group likely finalises separation terms
Godrej Agrovet, Godrej Industries, Godrej Properties can potentially rally up to 10% from current levels, while Astec Life and Godrej Consumer Products can fall up to 17%, suggest charts.
 "Strategies for Godrej stocks as group likely finalises separation terms")
Astec LifeSciences tumbles 10% on loss in Q4; stock down 44% in six months
The company reported a net loss of Rs 5 crore for Q4FY23 as against a net profit of Rs 43.10 crore in a year ago period.
 "Astec LifeSciences tumbles 10% on loss in Q4; stock down 44% in six months")
Astec LifeSciences launches its R&D centre in Maharashtra's Rabale
Astec LifeSciences, a subsidiary of Godrej Agrovet (GAVL), on Tuesday launched its Research and Development (R&D) centre in Rabale, Maharashtra. The facility 'Adi Godrej Centre for Chemical Research and Development' will focus on innovation and developing sustainable and safe solutions for people and the environment and providing services to innovator companies in the contract development & manufacturing space, the company said in a statement. "The CDMO (Contract Development and Manufacturing Organisation) market for chemicals in India is expected to grow at a CAGR of 12 per cent as against the global rate of 10 per cent. This underlines the potential in this sector, and our new facility will enable us to expand our offerings specifically in CDMO space," Astec LifeSciences Chief Executive Officer Anurag Roy said. It will also make the company a partner of choice through its improved ability of providing end-to-end solutions to customers from the R&D stage to development to
 "Astec LifeSciences launches its R&D centre in Maharashtra's Rabale")
Astec Lifesciences zooms 37% in two days on heavy volumes
With the rally in the past two days, the stock has bounced back 40 per cent from its 52-week low of Rs 1,050 touched recently on Tuesday, March 28
 "Astec Lifesciences zooms 37% in two days on heavy volumes")
Astec Lifesciences hits record high in a weak mkt; stock up 24% in 3 days
The stock of pesticides & agrochemicals company surpassed its previous high of Rs 2,178.85, which it had touched on July 20, 2022
 "Astec Lifesciences hits record high in a weak mkt; stock up 24% in 3 days")
Astec Life hits 52-wk high as ICRA reaffirms ratings, zooms 84% in 1 month
The domestic agrochemical industry has benefitted from the global supply-chain disruptions caused by the tightened environment regulations in China.
 "Astec Life hits 52-wk high as ICRA reaffirms ratings, zooms 84% in 1 month")
Astec Lifesciences rallies over 35% in two trading sessions post Q2 results
The stock rallied 16% to Rs 629, extending its Friday's 20% surge on BSE.
 "Astec Lifesciences rallies over 35% in two trading sessions post Q2 results")
